Atlas Trials

A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)

Clinical trial NCT02831634 · COMPLETED

Trial details

NCT number
NCT02831634
Sponsor
Institut Curie
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerCutaneous Melanoma
Start date
2016-06-09
Primary completion
2018-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.